Industries

Antibody Discovery and Engineering

Antibody discovery platforms generate therapeutic, diagnostic, and research-grade antibodies through display technologies, single B-cell sorting, and computational design. The industry heavily licenses phage display libraries and B-cell discovery workflows from university immunology groups, recruiting PhDs with deep in vitro selection expertise.

Details

Companies

AbCelleraImmunomedicsMorphoSysRegeneronAblynx SanofiHarbour BiomedLigand PharmaceuticalsAdimabDistributed BioSutro Biopharma

Market Size

$330B

Target Researchers

Immunologists and protein engineers with expertise in phage and yeast display, single B-cell sorting, humanization, bispecific antibody construction, Fc engineering, and affinity maturation

Use Cases

Antibody library licensingHumanization and optimization servicesBispecific antibody co-developmentADC linker-payload partnershipsFc engineering IP licensingSingle-cell discovery platform access